These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15067862)

  • 1. Towards error-free HIV diagnosis: guidelines on laboratory practice.
    Parry JV; Mortimer PP; Perry KR; Pillay D; Zuckerman M;
    Commun Dis Public Health; 2003 Dec; 6(4):334-50. PubMed ID: 15067862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.
    Wesolowski LG; Wroblewski K; Bennett SB; Parker MM; Hagan C; Ethridge SF; Rhodes J; Sullivan TJ; Ignacio-Hernando I; Werner BG; Owen SM
    J Clin Virol; 2015 Apr; 65():6-10. PubMed ID: 25766979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First nucleic acid test approved to detect divergent HIV types.
    AIDS Patient Care STDS; 2009 Apr; 23(4):311. PubMed ID: 19367695
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance of rapid HIV-1/HIV-2 INSTI on plasma and capillary blood for serological diagnosis of non B subtypes and circulating recombinant forms of HIV-1 in Gabon.
    Ndjoyi-Mbiguino A; Nzengui Nzengui GF; Robin L; M'Boyis Kamdem H; Bélec L
    Med Mal Infect; 2015 Aug; 45(8):339-40. PubMed ID: 26159380
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of two HIV-POCT tests to identify false reactives.
    Teague A; Rossi M; Gilmour C; Watson L; Atkins M; McOwan A
    Int J STD AIDS; 2009 Nov; 20(11):808-9. PubMed ID: 19854884
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of HIV laboratory testing in Tanzania: a situation analysis.
    Mfinanga GS; Mutayoba B; Mbogo G; Kahwa A; Kimaro G; Mhame PP; Mwangi C; Malecela MN; Kitua AY
    Tanzan Health Res Bull; 2007 Jan; 9(1):44-7. PubMed ID: 17547100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approves new HIV blood test from Roche.
    AIDS Read; 2009 Mar; 19(3):123. PubMed ID: 19338065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].
    Fujii T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():434-7. PubMed ID: 16111295
    [No Abstract]   [Full Text] [Related]  

  • 9. Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.
    Kadivar K; Malloch L; Adonsou-Hoyi Y; Ng D; Lavoie S; Pulido K; Kim J
    J Clin Virol; 2013 Sep; 58(1):303-5. PubMed ID: 23890809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for laboratory test result reporting of human immunodeficiency virus type 1 ribonucleic acid determination. Recommendations from a CDC working group. Centers for Disease Control.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2001 Nov; 50(RR-20):1-12. PubMed ID: 11952031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights from the 2016 HIV diagnostics conference: The new landscape of HIV testing in laboratories, public health programs and clinical practice.
    Wesolowski LG; Parker MM; Delaney KP; Owen SM
    J Clin Virol; 2017 Jun; 91():63-68. PubMed ID: 28209395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of HIV infection and laboratory monitoring of its therapy.
    Yilmaz G
    J Clin Virol; 2001 Jun; 21(3):187-96. PubMed ID: 11397655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological exploration of individuals with discordant HIV screening tests.
    Pasquier C; Sandres-Sauné K; Mansuy JM; Puissant B; Viraben R; Spenato N; Miédougé M; Massip P; Blancher A; Izopet J
    J Clin Virol; 2004 Jul; 30(3):218-23. PubMed ID: 15135738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV prevalence and strain diversity in Gabon: the end of a paradox.
    Makuwa M; Souquière S; Apetrei C; Tevi-Benissan C; Bedjabaga I; Simon F
    AIDS; 2000 Jun; 14(9):1275-6. PubMed ID: 10894293
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid testing stalled.
    Huff B
    GMHC Treat Issues; 2002 Feb; 16(2):1-3. PubMed ID: 11924462
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on the human immunodeficiency virus.
    Brun-Vézinet F; Charpentier C
    Med Mal Infect; 2013 May; 43(5):177-84. PubMed ID: 23628423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual HIV infection.
    Cheonis N
    BETA; 2006; 18(2):36-40. PubMed ID: 16610118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.